Viewing Study NCT02023593


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-02-28 @ 3:30 AM
Study NCT ID: NCT02023593
Status: COMPLETED
Last Update Posted: 2023-02-16
First Post: 2013-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma
Sponsor: Yuhong Li
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Esophageal Carcinoma View
Keywords: